These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


353 related items for PubMed ID: 18977695

  • 1. C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation.
    Beinrohr L, Dobó J, Závodszky P, Gál P.
    Trends Mol Med; 2008 Dec; 14(12):511-21. PubMed ID: 18977695
    [Abstract] [Full Text] [Related]

  • 2. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.
    Kerr FK, Thomas AR, Wijeyewickrema LC, Whisstock JC, Boyd SE, Kaiserman D, Matthews AY, Bird PI, Thielens NM, Rossi V, Pike RN.
    Mol Immunol; 2008 Feb; 45(3):670-7. PubMed ID: 17709141
    [Abstract] [Full Text] [Related]

  • 3. Recombinant C1 inhibitor in brain ischemic injury.
    Gesuete R, Storini C, Fantin A, Stravalaci M, Zanier ER, Orsini F, Vietsch H, Mannesse ML, Ziere B, Gobbi M, De Simoni MG.
    Ann Neurol; 2009 Sep; 66(3):332-42. PubMed ID: 19798727
    [Abstract] [Full Text] [Related]

  • 4. Plasma-derived mannose-binding lectin shows a direct interaction with C1-inhibitor.
    Keizer MP, Kamp AM, Brouwer N, van de Wetering MD, Wouters D, Kuijpers TW.
    Mol Immunol; 2014 Apr; 58(2):187-93. PubMed ID: 24368318
    [Abstract] [Full Text] [Related]

  • 5. Assembly of C1 and the MBL- and ficolin-MASP complexes: structural insights.
    Gaboriaud C, Teillet F, Gregory LA, Thielens NM, Arlaud GJ.
    Immunobiology; 2007 Apr; 212(4-5):279-88. PubMed ID: 17544813
    [Abstract] [Full Text] [Related]

  • 6. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW, Waage C, Fure H, Brekke OL, Sfyroera G, Lambris JD, Mollnes TE.
    Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
    [Abstract] [Full Text] [Related]

  • 7. Structure and function of complement activating enzyme complexes: C1 and MBL-MASPs.
    Gál P, Ambrus G.
    Curr Protein Pept Sci; 2001 Mar; 2(1):43-59. PubMed ID: 12369900
    [Abstract] [Full Text] [Related]

  • 8. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins.
    Thiel S.
    Mol Immunol; 2007 Sep; 44(16):3875-88. PubMed ID: 17768106
    [Abstract] [Full Text] [Related]

  • 9. The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency.
    Csuka D, Munthe-Fog L, Skjoedt MO, Kocsis A, Zotter Z, Gál P, Varga L, Farkas H, Füst G, Garred P.
    Mol Immunol; 2013 Jul; 54(3-4):271-7. PubMed ID: 23318225
    [Abstract] [Full Text] [Related]

  • 10. The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while α2-macroglobulin is not.
    Paréj K, Dobó J, Závodszky P, Gál P.
    Mol Immunol; 2013 Jul; 54(3-4):415-22. PubMed ID: 23399388
    [Abstract] [Full Text] [Related]

  • 11. A novel measurement method for activation of the lectin complement pathway via both mannose-binding lectin (MBL) and L-ficolin.
    Inoshita H, Matsushita M, Koide S, Kusaba G, Ishii M, Onda K, Gi MJ, Nakata M, Ohsawa I, Horikoshi S, Ohi H, Tomino Y.
    J Immunol Methods; 2009 Sep 30; 349(1-2):9-17. PubMed ID: 19699205
    [Abstract] [Full Text] [Related]

  • 12. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.
    Kozarcanin H, Lood C, Munthe-Fog L, Sandholm K, Hamad OA, Bengtsson AA, Skjoedt MO, Huber-Lang M, Garred P, Ekdahl KN, Nilsson B.
    J Thromb Haemost; 2016 Mar 30; 14(3):531-45. PubMed ID: 26614707
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.
    Salvesen B, Nielsen EW, Harboe M, Saugstad OD, Mollnes TE.
    Mol Immunol; 2009 Feb 30; 46(4):688-94. PubMed ID: 18950866
    [Abstract] [Full Text] [Related]

  • 14. Early complement proteases: C1r, C1s and MASPs. A structural insight into activation and functions.
    Gál P, Dobó J, Závodszky P, Sim RB.
    Mol Immunol; 2009 Sep 30; 46(14):2745-52. PubMed ID: 19477526
    [Abstract] [Full Text] [Related]

  • 15. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
    Kovacsovics TJ, Peitsch MC, Kress A, Isliker H.
    J Immunol; 1987 Mar 15; 138(6):1864-70. PubMed ID: 3029222
    [Abstract] [Full Text] [Related]

  • 16. Effects of C1 inhibitor on tissue damage in a porcine model of controlled hemorrhage.
    Dalle Lucca JJ, Li Y, Simovic M, Pusateri AE, Falabella M, Dubick MA, Tsokos GC.
    Shock; 2012 Jul 15; 38(1):82-91. PubMed ID: 22683724
    [Abstract] [Full Text] [Related]

  • 17. The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions.
    Harmat V, Gál P, Kardos J, Szilágyi K, Ambrus G, Végh B, Náray-Szabó G, Závodszky P.
    J Mol Biol; 2004 Oct 01; 342(5):1533-46. PubMed ID: 15364579
    [Abstract] [Full Text] [Related]

  • 18. Production and purification of recombinants of mouse MASP-2 and sMAP.
    Iwaki D, Fujita T.
    J Endotoxin Res; 2005 Oct 01; 11(1):47-50. PubMed ID: 15826378
    [Abstract] [Full Text] [Related]

  • 19. Functional characterization of the recombinant human C1 inhibitor serpin domain: insights into heparin binding.
    Rossi V, Bally I, Ancelet S, Xu Y, Frémeaux-Bacchi V, Vivès RR, Sadir R, Thielens N, Arlaud GJ.
    J Immunol; 2010 May 01; 184(9):4982-9. PubMed ID: 20351192
    [Abstract] [Full Text] [Related]

  • 20. MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation.
    Degn SE, Hansen AG, Steffensen R, Jacobsen C, Jensenius JC, Thiel S.
    J Immunol; 2009 Dec 01; 183(11):7371-8. PubMed ID: 19917686
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.